TXMD: TherapeuticsMD Inc Company Short-Term Debt

Symbol and logo of brand TherapeuticsMD Corp (TXMD)

Short-term debts of TherapeuticsMD, Inc. (TXMD) on the GURU.Markets terminal display liability dynamics, where 0.00 shows the value of this parameter, which correlates with insurance payout risks and regulatory standards. The implementation of automated dispensers and molecule analysis software optimizes research. The business model relies on receiving royalties through third-party distributors, which minimizes logistics costs and enhances scalability.

TXMD (therapeuticsmd.com) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

TXMD (TherapeuticsMD Inc): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart TherapeuticsMD Corp|TXMD - Fair Value Consensus
- market capitalization information:
Market Value TherapeuticsMD, Inc.|TXMD - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share TherapeuticsMD|TXMD - Book Capitalization|Market Cap to Net Assets Ratio therapeuticsmd.com|TXMD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Equity Ratio TherapeuticsMD, Inc.|TXMD - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity TherapeuticsMD Corp|TXMD - Company Cumulative Debt|Debt to Book Capitalization Ratio TherapeuticsMD, Inc.|TXMD - Company Long-Term Liabilities|Company Short-Term Debts TherapeuticsMD|Quick Liquidity therapeuticsmd.com
- net income and valuation multiples indicators:
TXMD - Company Profit
Basic company analysis:TXMD - therapeuticsmd.com
Flagship merchandise of TherapeuticsMD Corp

This indicator captures the volume of obligations with a maturity of up to one year, allowing for an assessment of liquidity and the risk of interest overpayments when managing working capital. By analyzing the short-term financial liabilities of TherapeuticsMD, Inc. (TXMD), one can confirm the effectiveness of the asset-light model, where outsourcing production to external partners minimizes the need for borrowed capital, ensuring high financial stability for the business.

Competitor analysis

OGN - Company Short-Term Debt|Company Short-Term Loans and Borrowings DARE (Dare Bioscience)|Palatin (PTN) - Company Short-Term Debt